| |
| |
|
| Insider
Information: |
Bratton Capital Inc. |
| Relationship: |
10% Owner |
| City: |
Fort Worth |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
75,085 |
|
|
Indirect Shares
|
23,704,928 |
|
|
| Direct
Value |
$232,013 |
|
|
|
Indirect Value
|
$258,957,097 |
|
|
| Total
Shares |
23,780,013 |
|
|
| Total
Value |
$259,189,110 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
6
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 859.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aquestive Therapeutics, Inc. |
AQST |
10% Owner |
2018-07-24 |
75,085 |
2018-07-24 |
11,503,294 |
Premium* |
|
|
Denali Therapeutics Inc. |
DNLI |
10% Owner |
2019-03-25 |
0 |
2020-12-21 |
12,201,634 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
10% Owner |
– – • |
2020-12-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(383,411) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
10% Owner |
– – • |
2020-12-14 |
4 |
S |
$80.35 |
$1,432,842 |
I/I |
(17,825) |
383,411 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
10% Owner |
– – • |
2020-12-11 |
4 |
S |
$80.05 |
$3,746,442 |
I/I |
(46,799) |
401,236 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
10% Owner |
– – • |
2020-06-30 |
4 |
S |
$24.01 |
$1,088,601 |
I/I |
(45,345) |
448,035 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
10% Owner |
– – • |
2020-06-29 |
4 |
S |
$23.84 |
$1,982,373 |
I/I |
(82,578) |
493,380 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
10% Owner |
– – • |
2020-06-26 |
4 |
S |
$23.84 |
$2,922,078 |
I/I |
(122,077) |
575,958 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
10% Owner |
– – • |
2020-06-23 |
4 |
S |
$25.69 |
$515,969 |
I/I |
(20,024) |
698,035 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
10% Owner |
– – • |
2020-06-22 |
4 |
S |
$24.66 |
$2,231,902 |
I/I |
(90,056) |
718,059 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
10% Owner |
– – • |
2020-06-19 |
4 |
S |
$24.20 |
$3,556,503 |
I/I |
(144,920) |
808,115 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
10% Owner |
– – • |
2019-03-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(158,764) |
953,035 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
10% Owner |
– – • |
2018-07-24 |
4 |
B |
$15.00 |
$2,475,000 |
I/I |
165,000 |
165,000 |
1.5 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
